Yuka O. Takahashi

Musashino, 1808610, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.

Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.

Journal: Nutrients

Published: April 01, 2026

Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.

Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.

Journal: Diagnostics (Basel, Switzerland)

Published: March 30, 2026

Lactulose and rifaximin combination therapy as first-line treatment for preventing recurrent overt hepatic encephalopathy: a retrospective observational study.

Lactulose and rifaximin combination therapy as first-line treatment for preventing recurrent overt hepatic encephalopathy: a retrospective observational study.

Journal: European journal of gastroenterology & hepatology

Published: November 17, 2025

Effects of short-term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP-ELM study.

Effects of short-term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP-ELM study.

Journal: Journal of diabetes investigation

Published: October 13, 2025

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Journal: PloS one

Published: June 08, 2025

Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study.

Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study.

Journal: International journal of endocrinology

Published: September 18, 2024

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 27, 2023

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Journal of gastroenterology and hepatology

Published: October 10, 2023

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: October 01, 2023

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis.

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis.

Journal: Pharmaceutics

Published: July 26, 2023

Encapsulated Papillary Carcinoma in an Elderly Male Whose Diagnosis Was Difficult before Surgery: A Case Report.

Encapsulated Papillary Carcinoma in an Elderly Male Whose Diagnosis Was Difficult before Surgery: A Case Report.

Journal: Case reports in oncology

Published: June 19, 2023

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Journal: Clinical case reports

Published: May 02, 2023

Showing 1-12 of 110

Last Updated: 09/26/2026